Table 2.
Inhibition of rat and human nNOS compared to murine and human iNOS by selected compoundsa
Ki (μM) | Selectivity | ||||||
---|---|---|---|---|---|---|---|
compd | rnNOS | hnNOS | miNOS | hiNOS | rn/mi | hn/hi | |
7 | 0.045 | 0.088 | 16.3 | 6.94 | 362 | 79 | |
10 | 0.119 | 0.151 | 2.86 | 3.55 | 24 | 24 | |
12 | 0.055 | 0.060 | 24.2 | 29.9 | 441 | 498 | |
29 | 0.039 | 0.046 | 32.8 | 21.1 | 841 | 459 | |
32 | 0.052 | 0.076 | 45.7 | 43.9 | 879 | 578 | |
33 | 0.044 | 0.045 | 8.18 | 29.4 | 186 | 653 | |
36 | 0.043 | 0.063 | 16.4 | 24.6 | 382 | 390 | |
37 | 0.053 | 0.046 | 21.0 | 34.8 | 397 | 757 |
Compounds 7, 10, 12, 29, 32, 33, 36, and 37 were assayed for in vitro inhibition against purified human iNOS (hiNOS) using known literature methods, and Ki values were calculated directly from IC50 values using the Cheng–Prusoff equation. IC50 values are the average of at least two replicates from 6–9 data points; all experimental standard error values (for the LogIC50) are less than ± 0.10. Ki values for isoforms: rat nNOS (rnNOS), human nNOS (hnNOS), and murine iNOS (miNOS) were included for comparison. Selectivity values are ratios of respective Ki values.